Loading…
Crane Company
🏹 Trader: 🎯 Near 52W High View all →
$11.7B
Market Cap
29.5
P/E
2.22
PEG
14.2%
ROCE
17.9%
ROE
0.59
D/E
17.8%
OPM
-11.9%
% from 52W High
54
α RS
🔍 CR is showing a high-conviction setup because it matches 5 of 39 tracked screener presets, Sector RRG has Industrials in the Improving quadrant with the trail still strengthening, and an ECS of 62.4 last quarter. Net: Broad signal stack, not a recommendation. ? Conviction RRG ECS
Sources
Conviction 5/39 · Industrials in Improving quadrant · ECS 62.4
⚖️ Compare 🔒 Generate Report 🔒 Research Packet 📚 Guides
🌏 Global Investor Returns
Currency-adjusted total returns for CR including FX impact
🌏
Click 🌏 Returns tab to load data
📈 Price History
Ratio Health
Excellent
Good
Average
Poor
By Category
📊 Sector Averages
About

Crane Company, together with its subsidiaries, engages in the manufacture and sale of engineered industrial products in the United States, Canada, the United Kingdom, Continental Europe, and internationally. The company operates in two segments, Aerospace & Advanced Technologies and Process Flow Technologies. The Aerospace & Electronics segment supplies critical components and systems, including original equipment and aftermarket parts for commercial aerospace, as well as the military aerospace, defense, and space markets. This segment also offers pressure sensors for aircraft engine control, aircraft braking systems for commercial aircraft and fighter jets, power conversion solutions for defense, and space applications and lubrication systems. The Process Flow Technologies segment provides process valves and related products, pumps and systems, and commercial valves; valve positioning and control systems, vacuum insulated pipe systems, and valve diagnostic and calibration systems; pumps and systems; and commercial valves. The company was formerly known as Crane Holdings, Co. Crane Company was founded in 1855 and is based in Stamford, Connecticut.

Key Ratios Snapshot
📈 Growth Pattern
📊 Quick Scorecard
Loading…
⭐ Superinvestors Holding CR
View All Superinvestors →
Manager Shares Value % of Fund Period
Steve Cohen Point72 Asset Management 429.8K $73.5M 0.09% Mar 2026
Jim Simons Renaissance Technologies LLC 161.3K $27.6M 0.04% Mar 2026

SEC Form 13F data. 45-day lag from quarter end.

🔒
Premium Feature
AI-generated 10-section company profile — business model, financials, strengths, risks & management quality
Upgrade to Premium
Already a member? Log in
📐
3-Statement Financial Model
Bear / Base / Bull projections · DCF fair value · Reverse-DCF
Open Model →
🎙 Management Tone Confident Specific → Stable 4 quarters Full tone analysis in Intelligence →
📊 MIXED Crane Q1 2026: EPS $1.65 (+15% YoY), 4% core sales growth, raises FY outlook to $6.65-$6.85
Revenue & Profitability
Adjusted EPS was $1.65, up 15% over prior year. Total sales increased 25% year-over-year, with 4% core growth. Adjusted operating profit increased 29%. AAT segment margin was 24.6%, PFT margin was 22.1%. Corporate expense was $24 million in the quarter. Full-year adjusted EPS guidance raised to $6.65-$6.85.
Outlook
Management sees a strong aerospace and defense demand environment, with commercial OE healthy and defense procurement spending solid. However, geopolitical uncertainty, elevated energy prices, and potential disruption to long-haul travel through the Middle East could pressure commercial aftermarket. PFT end markets show strength in power generation, pharma, cryogenics, and wastewater, but chemical remains sluggish.
Growth Drivers
Key growth drivers include strong defense demand (missile defense, radar), commercial OE at AAT, and PFT's power generation, pharma, cryogenics, and nuclear markets. Acquisitions are outperforming expectations with margin improvement. Commercial aftermarket orders were up 11% in Q1, but guidance assumes a full-year decline. Cryogenics (4-5% of PFT) growing mid-teens, driven by space launch.
Balance Sheet & CapEx
Not discussed in this earnings call.
Margins
AAT adjusted segment margin was 24.6% (down from 26.2% due to Druck acquisition), nearly 200 bps better than expected. PFT margin improved 50 bps to 22.1% despite dilutive acquisitions. For full year, PFT expects 30-35% operating leverage; AAT expects 35-40% leverage. Acquisitions are expected to add at least $0.15 EPS accretion in 2026 and improve margins by at least 300 bps.
Key Risks
Risks include geopolitical dynamics, elevated energy prices, inflation, and potential decline in commercial aftermarket due to Middle East conflict. Only about 5% of PFT sales are directly exposed to the Middle East. Freight and other inflationary headwinds are expected, but teams are executing to offset. Tariffs are not material. The company assumes conservative outlook for commercial aftermarket.
Generated by AI · Q1 2026 results · Not investment advice
🔒
Free Account Required

Create a free Finmagine account to access Finmagine™ Scorecard.

See how this company scores across 5 dimensions — Financial Health, Growth Prospects, Competitive Position, Management Quality, and Valuation — powered by 30+ computed ratios.

Create Free AccountLog In
🔒
Premium Feature

Upgrade to Finmagine Premium to unlock Ask AI.

Get 25 expert AI analysis templates — Business KPIs, Comprehensive, Forensic Governance, Peer Comparison, Risk-Reward, Full Research Report, IPO Decoder, Red Flag Detector, and more — ready to paste into ChatGPT, Claude, Gemini, or Perplexity.

Upgrade to PremiumCreate Free Account
🔒
Premium Feature

Upgrade to Finmagine Premium to unlock Peer Comparison.

Compare this company side-by-side against its sector peers with financial metrics, ratio benchmarking, and relative performance across all key dimensions.

Upgrade to PremiumCreate Free Account
✓ 📞 Earnings Call Transcripts (5 quarters) submit a missing quarter
🔍
🔎 See cross-company document search → ?
📞 Earnings Call Transcripts (5)
Q2 2026 Q2 2026 2026-07-29
Record Q2 results featured 26% sales growth, margin expansion, and strong execution across both segments. Acquisitions outperformed, raising full-year EPS guidance to $6.85-$7.05. Backlog and demand trends support a positive outlook for the second half and beyond.
Q1 2026 Q1 2026 2026-04-28
First quarter 2026 results exceeded expectations with 25% sales growth, strong acquisition performance, and raised full-year EPS guidance to $6.65–$6.85. Aerospace & Advanced Technologies and Process Flow Technologies both delivered robust results, while proactive cost and pricing actions are offsetting inflation and geopolitical risks.
Q4 2025 Q4 2025 2026-01-27
Q4 2025 saw 5.4% core sales growth and 21% higher adjusted EPS, led by Aerospace and Advanced Technologies. Recent acquisitions expand the portfolio and are expected to be accretive in 2026, with guidance for 10% adjusted EPS growth at the midpoint. Net leverage remains moderate after M&A.
Q3 2025 Q3 2025 2025-10-28
Adjusted EPS rose to $1.64 on 5.6% core sales growth, with Aerospace & Electronics and Process Flow Technologies driving strong results. Full-year adjusted EPS guidance was raised to $5.75-$5.95, and the PSI acquisition is on track to close, expected to be accretive.
Q2 2025 Q2 2025 2025-07-29
Q2 2025 saw strong core sales and profit growth, led by Aerospace & Electronics and Process Flow Technologies, with record backlogs and robust demand. The PSI acquisition is set to enhance capabilities and drive future growth, while full-year EPS guidance was raised on continued execution.
🔒
Premium Feature

Upgrade to Finmagine Premium to unlock Catalyst Timeline.

Every result, order win, insider trade, ECS update, earnings-call, and SEC announcement for this company — in one chronological lane.

Upgrade to PremiumCreate Free Account
🔒
Premium Feature

Upgrade to Finmagine Premium to unlock Full Report.

Read the complete Finmagine™ investment research report — comprehensive fundamental analysis, business model assessment, competitive positioning, and investment recommendation.

Upgrade to PremiumCreate Free Account

📊 Analysis Methodology

This comprehensive investment analysis was conducted using The Finmagine™ Stock Analysis & Ranking Methodology, a proprietary framework that systematically evaluates stocks across five critical dimensions: Financial Health, Growth Prospects, Competitive Positioning, Management Quality, and Valuation.

🎯
Discover Our Proven Investment Framework Learn how we analyze and rank stocks using advanced quantitative models, multi-dimensional scoring systems, and dynamic discriminatory ranking techniques that have guided successful investment decisions across market cycles.
📊 Explore The Finmagine™ Methodology

A comprehensive, bias-free framework for analyzing and ranking stocks by Financial Strength, Growth Potential, Competitive Edge, Management Quality, and Value.

Financial Model
Projections are built from each company's audited annual financials (Income Statement, Balance Sheet, Cash Flow) over the last 5 fiscal years. Forward assumptions — revenue growth %, EBITDA margin, D&A (USD millions), interest expense, tax rate, and capex — are AI-generated using historical context and refreshed twice a year: after the December results season and after the September/Q4 results season.

DCF Valuation
Fair Value = Σ(FCFt / (1+WACC)t) + Terminal Value. Terminal Value uses the Gordon Growth Model: FCF5 × (1+g) / (WACC−g). Default WACC: 10% (US risk-free ~4.5%, equity risk premium ~5.5%). Default terminal growth: 3% (long-run US nominal GDP proxy).

CAGR Tracker
Expected 5-year CAGR = (DCF Fair Value / Current Price)1/5 − 1. Assumes fair value is reached in exactly 5 years — a mechanical estimate only.

Data Sources & Limitations
Financial statements sourced from public filings. Prices updated daily. Forward assumptions are AI-generated. All monetary values in USD millions. Non-US ADR companies may have currency conversion inaccuracies. Models are point-in-time and do not update intra-quarter or account for M&A, macro shocks, or extraordinary items.

⚠️ Important Disclaimers — Please read without fail.

Investment Risk:
Investing in securities, including US equities and ETFs, involves inherent risks including the potential loss of principal. All investments are subject to market fluctuations, economic conditions, regulatory changes, and other factors that may affect their value. Past performance is not indicative of future results. This analysis is provided for informational and educational purposes only and should not be construed as investment advice under any circumstances.

No Investment Recommendation:
This analysis does not constitute, nor should it be interpreted as, an offer, solicitation, or recommendation to buy, sell, or hold any securities or financial products. Investors are strongly advised to conduct their own independent research and due diligence and to consult with a licensed financial advisor or an SEC-registered investment adviser before making any investment decisions, taking into account their individual financial situation, risk tolerance, and investment objectives.

Not SEC-Registered:
Finmagine is not registered as an investment adviser with the U.S. Securities and Exchange Commission (SEC) or any state securities authority. Nothing on this platform constitutes investment advice as defined under the Investment Advisers Act of 1940.

Conflict of Interest Disclosure:
The author and/or analyst may currently hold or have previously held positions in the securities discussed. Any such positions are not intended to influence the objectivity or independence of the analysis. This research is produced independently and is not sponsored, endorsed, or commissioned by any company or institution.

Information Sources:
The analysis is based on publicly available information including SEC filings (10-K, 10-Q), annual reports, management commentary, and publicly available financial data. Information is believed to be accurate as of the date of publication but may be subject to change without notice. Readers are encouraged to independently verify all information before acting upon it.

Forward-Looking Statements:
This analysis may contain forward-looking statements, forecasts, or projections that are inherently subject to risks, uncertainties, and assumptions. Actual results may differ materially from those expressed or implied. Finmagine does not undertake any obligation to update such statements in the future.

Limitation of Liability:
The content is provided "as is" without any warranties, express or implied. Finmagine expressly disclaims any liability for errors, omissions, or any losses incurred as a result of reliance on the information provided. Readers assume full responsibility for their investment decisions.